Gastroenterology
Volume 135, Issue 3 , Pages 781-786 , September 2008

Infectious Gastroenteritis and Risk of Developing Inflammatory Bowel Disease

  • Chad K. Porter

      Affiliations

    • Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland
    • Corresponding Author InformationAddress reprint requests to: Chad K. Porter, MPH, Enteric Diseases Department, Infectious Disease Directorate, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, Maryland 20910-7500. fax: (301) 319-7679
    • ,
  • David R. Tribble

      Affiliations

    • Uniformed Services University of the Health Sciences, Bethesda, Maryland
    • ,
  • Pablo A. Aliaga

      Affiliations

    • Defense Medical Surveillance System, Silver Spring, Maryland
    • ,
  • Heather A. Halvorson

      Affiliations

    • Defense Medical Surveillance System, Silver Spring, Maryland
    • ,
  • Mark S. Riddle

      Affiliations

    • Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland

Received 19 February 2008 ,Accepted 30 May 2008.

References 

  1. Bereswill S, Kist M. Recent developments in Campylobacter pathogenesis. Curr Opin Infect Dis. 2003;16:487–491
  2. Irving PM, Gibson PR. Infections and IBD. Nat Clin Pract. 2008;5:18–27
  3. Halvorson HA, Schlett CD, Riddle MS. Post-infectious irritable bowel syndrome—a meta-analysis. Am J Gastroenterol. 2006;101:1894–1899
  4. Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006;130:1588–1594
  5. Ternhag A, Torner A, Svensson A, et al. Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis. 2008;14:143–148
  6. Quigley EM. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?. Chin J Dig Dis. 2005;6:122–132
  7. Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease?. Gastroenterol Clin North Am. 2005;34:235–245vi–vii
  8. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health. 2002;92:1900–1904
  9. Hennessy TW, Marcus R, Deneen V, et al. Survey of physician diagnostic practices for patients with acute diarrhea: clinical and public health implications. Clin Infect Dis. 2004;38(Suppl 3):S203–S211
  10. Lewis JD, Brensinger C, Bilker WB, et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf. 2002;11:211–218
  11. Hosmer WH, Lemeshow S. Applied logistic regression. 2nd ed.. New York: John Wiley & Sons, Inc; 2000;
  12. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117:514–521
  13. Eckburg PB, Relman DA. The role of microbes in Crohn's disease. Clin Infect Dis. 2007;44:256–262
  14. Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol. 2006;12:4807–4812
  15. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640
  16. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis. 2006;12:925–933
  17. Bevins CL. Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans. 2006;34:263–266
  18. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol. 2007;19:70–83
  19. Bevins CL. Events at the host-microbial interface of the gastrointestinal tract (V. Paneth cell alpha-defensins in intestinal host defense). Am J Physiol Gastrointest Liver Physiol. 2005;289:G173–G176
  20. Wehkamp J, Fellermann K, Stange EF. Human defensins in Crohn's disease. Chem Immunol Allergy. 2005;86:42–54
  21. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A. 2005;102:18129–18134
  22. Wehkamp J, Schmid M, Fellermann K, et al. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol. 2005;77:460–465
  23. Giallourakis C, Stoll M, Miller K, et al. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet. 2003;73:205–211
  24. Rioux JD, Daly MJ, Silverberg MS, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet. 2001;29:223–228
  25. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39:596–604
  26. Deretic V. Autophagy in innate and adaptive immunity. Trends Immunol. 2005;26:523–528
  27. Deretic V. Autophagy as an immune defense mechanism. Curr Opin Immunol. 2006;18:375–382
  28. Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254–2261
  29. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol. 2001;36:2–15
  30. Rogers BH, Clark LM, Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis. 1971;24:743–773
  31. Centers for Disease Control and Prevention. Cigarette smoking among adults—United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;53:427–431
  32. Haddock CK, Klesges RC, Talcott GW, et al. Smoking prevalence and risk factors for smoking in a population of United States Air Force basic trainees. Tob Control. 1998;7:232–235
  33. Mahid SS, Minor KS, Stromberg AJ, et al. Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:431–438
  34. Karban A, Eliakim R. Effect of smoking on inflammatory bowel disease: is it disease or organ specific?. World J Gastroenterol. 2007;13:2150–2152
  35. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–1471
  36. Montgomery SM, Ekbom A. Epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol. 2002;18:416–420
  37. Lindberg E, Tysk C, Andersson K, et al. Smoking and inflammatory bowel disease (A case control study). Gut. 1988;29:352–357
  38. Tobin MV, Logan RF, Langman MJ, et al. Cigarette smoking and inflammatory bowel disease. Gastroenterology. 1987;93:316–321
  39. Somerville KW, Logan RF, Edmond M, et al. Smoking and Crohn's disease. Br Med J (Clin Res Ed). 1984;289:954–956
  40. Burgmann T, Clara I, Graff L, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis—how much is irritable bowel syndrome?. Clin Gastroenterol Hepatol. 2006;4:614–620
  41. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389–396
  42. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149:916–924
  43. Songer TJ, LaPorte RE. Disabilities due to injury in the military. Am J Prev Med. 2000;18:33–40

 This study was conducted under support of the Military Infectious Disease Research Program and Department of Defense Global Emerging Infections Surveillance and Response System funding.

 The opinions and assertions herein should not be construed as official or representing the views of the Department of the Navy, Department of the Army, the Department of Defense, or the US Government. This is a US Government work. There are no restrictions on its use. There were no financial conflicts of interests among any of the authors.

 Authors are employees of the US Government or military service members. This work was prepared as part of official duties. Title 17 U.S.C. §105 provides that “Copyright protection under this title is not available for any work of the United States Government.” Title 17 U.S.C. §101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person's official duties.

PII: S0016-5085(08)00957-8

doi: 10.1053/j.gastro.2008.05.081

Gastroenterology
Volume 135, Issue 3 , Pages 781-786 , September 2008

Article Tools